Company intelligence / Profile preview

Deerfield Management

Ownership: Private
Employees: ~200
Development stage: Other

Overview

As an investment firm rather than a drug developer or biotech company itself, Deerfield does not have its own clinical results. Its portfolio includes over 200 private and public healthcare companies at all stages of development. It has been instrumental in the creation and funding of numerous successful startups that have advanced to clinical trials or commercialization.

Modalities: Small moleculeMonoclonal antibodyGene therapymRNA-based drugsMedical devicesDigital health technologies
Industry: Investors

Partnerships

Collaborations with ~29 leading academic research institutions for early-stage discovery/commercialization supportIndustry partners include pharmaceutical firms via co-investments

Beyond the preview

Go deeper on Deerfield Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deerfield Management.

Explore the full profile